title: Comparison of dietary and lifestyle habits among stage III and metastatic colorectal cancer patients: findings from CALGB 89803 and CALGB 80405.
abstract: Self-administered questionnaires were completed by patients undergoing chemotherapy for stage III colon cancer (n=1095) and metastatic colorectal cancer (n=875). We describe the prevalence of a wide-range of health-related dietary patterns and lifestyle behaviors among colorectal cancer patients with stage III and metastatic disease and report notable similarities in these 2 cohorts.
  
  
  BACKGROUND
  Cancer patients often pursue lifestyle and dietary changes with the aim to improve outcomes. Using data from 2 large National Cancer Institute-sponsored clinical trials, we report on the dietary and lifestyle practices of patients receiving therapy for stage III colon or metastatic colorectal cancer.
  
  
  METHODS
  Self-administered questionnaires were completed by patients undergoing chemotherapy for stage III colon cancer (n=1095) and metastatic colorectal cancer (n=875). Descriptive statistical analyses were performed to evaluate anthropometrics, diet, and lifestyle in each cohort.
  
  
  RESULTS
  Median body mass index was comparable for stage III and metastatic patients (27.3 vs. 26.5 kg/m2). Stage III patients reported a modestly higher median level of physical activity than metastatic patients (4.6 vs. 3.4 metabolic equivalent task-hours per week). Ten percent of stage III and 9% of metastatic patients reported ongoing cigarette use. Avoidance of alcohol was reported by 47% of stage III and 43% of metastatic patients. Dietary patterns for both groups were comparable with more than 80% of stage III and metastatic patients failing to meet the recommended daily intake of vegetables, fruits, and milk products. Usage of at least 2 multivitamins per week was reported by 49% of stage III and 40% of metastatic patients. Two percent of stage III and 5% of metastatic patients reported vitamin D supplement use.
  
  
  CONCLUSIONS
  We observed notable similarities in dietary and lifestyle behaviors between stage III colon and metastatic colorectal cancer patients actively receiving chemotherapy. Future research should aim to elucidate the effect of these behaviors on patient outcomes.
authors: Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA 94115, USA. katherine.vanloon@ucsf.edu
authors: Katherine
authors: K
authors: Van Loon
authors: Devin
authors: D
authors: Wigler
authors: Donna
authors: D
authors: Niedzwiecki
authors: Alan P
authors: AP
authors: Venook
authors: Charles
authors: C
authors: Fuchs
authors: Charles
authors: C
authors: Blanke
authors: Leonard
authors: L
authors: Saltz
authors: Richard M
authors: RM
authors: Goldberg
authors: Jeffrey A
authors: JA
authors: Meyerhardt
mesh_terms: D000428:Alcohol Drinking / Q000453:epidemiology; D015331:Cohort Studies; D015179:Colorectal Neoplasms / Q000188:drug therapy / Q000453:epidemiology* / Q000473:pathology; D019587:Dietary Supplements; D005247:Feeding Behavior; D015438:Health Behavior; D006801:Humans; D008019:Life Style; D009043:Motor Activity; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging; D018673:Nutrition Policy; D015995:Prevalence; D012907:Smoking / Q000453:epidemiology; D011795:Surveys and Questionnaires; D014807:Vitamin D / Q000008:administration & dosage; D014815:Vitamins / Q000008:administration & dosage
chemical_list: D014815:Vitamins; D014807:Vitamin D